DAFTAR PUSTAKA
Agida ET, Adeka BI, Jibril KA. .,2010. Pregnancy Outcome in Preeclamptic at The University of Abuja Teaching Hospital, Gwagwalada, Abuja: A 3 Year Review. Nigerian Journal of Clinical Practice..; Vol. 13; 4: 394-398
Ahmad Shakil, and Ahmed Asif. 2004. Elevated Placental Soluble Vascular Endothelial Growth Factor receptor-1 Inhibits Angiogenesis in Preeclampsia. Circulation Research. Journal of The American Heart Association. : 95: 884-891
Ananth Cande V, Keyes Katherine M, Wapner Ronald J., 2013. Preeclampsia rates in the United States, 1980-2010: age Period Cohort Analysis. BMJ.; 347: 1-9
Anderson UD, Olsson MG, Kristensen KH, Akerstrom B, Hansson SR. Review:
Biochemical Markers to Predict Preeclampsia. 2012. PLACENTA33, Supplement A, Trophoblast Research.; vol. 26: s42-s47
Andraweera P H, Dekker G A, Roberts C T. 2012. The Vascular Endothelial Growth Factor Family in Adverse Pregnancy Outcomes. Human Reproduction Update.; vol. 18: 436-457
Badan Kependudukan dan Keluarga Berencana Nasional. 2012 dalam Survey Kesehatan dan Demografi Indonesia. 2013. Jakarta; Indonesia; hal 213
Barton J R and Sibai B M. 2008. Prediction and Prevention of Recurrent Preeclampsia. Obstet Gynecol. ; 112(2): 359-72
Chappell Lucy C, Duckworth Suzy, Seed Paul T, Griffin Melanie, Myers Jenny, Mackillop Lucy, Simpson Ngel, Waugh Jason, Anumba Dilly et al. 2013.
Diagnostic Accuracy of Placental Growth Factor in Women with Suspected Preeclampsia: A Prospective Multicenter Study. Circulation Research. Journal of The American Heart Association.; 128: 2121-2131
Chen Yu. 2009. Novel Angiogenic Factor for Predicting Preeclampsia: sFlt-1, PlGF and Soluble Endoglin. The Open Clinical Chemistry Journal.; 2: 1-6
Costa F S, Murthi P, Keogh R, Woodrow N. . 2011.Early Screening for Preeclampsia. Rev Bras Ginecol Obstet; 33 (11): 367-75
Eiland Elosha, Nzerue Chuke, Faulkner Marquetta. 2012. Review Article Preeclampsia 2012. Journal of Pregnancy.: 1-7
Gilbert J S, Ryan m J, Lamarca B B, Sedeek M, Murphy S R and Granger J P. 2008. Pathophysiology of Hypertension During Preeclampsia: Linking Placental Ischemia with Endothelial Dysfunction. Am. J Physiol Heart Circ Physiol; (294): H541-H550
Grill S, Rusterholz C, Dallenbach RZ, Tercanli S, Holzgreve W, Hahn S, and Lapaire O. 2009. Potential Markers of Preeclampsia- A Review.
Reproductive Bilogy and Endocrinology.; 7 (70): 1-14
Gu Y, Lewis D F and Wang y. 2008. Placental Productions and Expressions of Soluble Endoglin, Soluble fms-Like Tyrosine Kinase Receptor-1 and Placental Growth Factor in Normal and Preeclamptic Pregnancies. J Clin Endocrin ol Metab.; 93(1): 260-266
Hagmann Henning, Thadhani Ravi, Benzing Thomas, Karumanchi S Ananth, Stephan Holger. 2012. The Promise of Angiogenic Markers for the Early Diagnosis and Prediction of Preeclampsia. Clinical Chemistry.; 58: 5. 837-845
Hanita O, Alia N N, Zaleha A M, Azlin M N. 2014. Serum Soluble FMS-Like Tyrosine Kinase 1 and Placental Growth Factor Concentration as Predictors of Preeclampsia in High Risk Pregnant Women. Malaysian J. Pathol.; 36: 19-26
Harris L K. 2011. Transformation of The Spiral Arteries in Human Pregnancy: Key Event in The Remodelling Timeline. J. Placenta; Vol 25; (32): s154-s158
Hassan Mahmoud Fathy, Rund Nancy Mohamed Ali and Salama Ahmed Husseiny. 2013. An Elevated maternal Plasma Soluble fms Like Tyrosine Kinase-1 to Plaental Growth Factor Ratio at Midtrimester is a Useful Predictor for Preeclampsia. Obstetrics and Gynecology International.; 1-8
Hernawati, Ina. 2011. Analisis Kematian Ibu di Indonesia. Dalam Paparan Direktur pada Pertemuan teknis Kesehatan ibu. 6 April 2011.
Hui Dini, Okun Nan, Murphy Kellie, Kingdom John, Uleryk Elizabeth, Shah Prakesh S. . 2012. Combination of Maternal Serum Markers to Predict Preeclampsia, Small for Gestational Age and Stillbirth: A Systematic Review. Journal Obstetric Gynecology Canada; 34(2): 142-153
Hunter Alyson, Aitkenhead Mark, Caldwell Carolyn, McCracken Geoffrey, Wilson David and McClure Neil. 2000. Serum Levels of Vascular Endothelial Growth Factor in Preeclamptic and Normotensive Pregnancy. Hypertension. American Heart Association Journals.; 36: 965-969
Jacobs Marni, Nassar Natasha, Roberts Christine L, Hadfield Ruth, Morris Jonathan M and Ashton Anthony W. 2011. Levels of Soluble fms-lik Tyrosine Kinase One in First Trimester and Outcomes of Pregnancy: a Systematic Review. Reproductive Biology and Endrocinology. ; 9:1-8
Jido T A, Yakasai I A. 2013. Preeclampsia: a Review of The Evidence. Annals of African Medicine.; vol 12: 75-86
Kapiteijn Catharina Johanna. 2006. Angiogenesis and The Inception of Pregnancy.
Karumanchi SA, Epstein F H. 2007. Placental Ischemia and Soluble fms-Like Tyrosine Kinase 1: Cause or Consequence of Preeclampsia ? Kidney International.; 71: 959-961
Kemenkes. 2008. Angka Kematian Ibu Melahirkan. Diunduh dari : http://menegpp.go.id/v2/index.php/datadaninformasi/kesehatan?downloa d=23%3Aangka-kematian-ibu-melahirkan-akiWHO
Kemenkes, 2011. Profil Data Kesehatan Indonesia tahun 2011. Diunduh dari http://www.depkes.go.id
Kemenkes. 2012. Tren Angka Kematian Ibu sejak 1992 sampai tahun 2012 dalam SDKI 2012.
Kim Shin Young, Ryu Hyun Mee, Yang Jae Hyug, Kim Moon Young, Han Jung Yeol, Kim Joo Oh, Chung Jin Hoon, Park So Yeon, Lee Moon Hee, Kim Do Jin. 2007. Increased sFlt-1 to PlGF Ratio in Women Who Subsequently Develop Preeclampsia. Journal Korean Med Science.; 22: 873-7
Knofler M, Pollheimer J. 2012. Molecular Regulation of Human Trophoblast Invasion. Placenta 33, Supp A Trophoblast Reseaerch. . Vol 26: s55-s62
Lapaire O, Grill Simon, Lalevee S, Kolla V, Hosl I, Hahn S. 2012. Microarray Screening for Novel Preeclampsia Biomarker Candidates. Fetal Diagnosis Therapy. ; 31: 147-153
Leif Matthiesen, Berg Goran, Ernerudh Jan, Ekerfelt Christina, Jonsson Yvonne, Sharma Surendra. 2005. Immunology of Preeclampsia. Chem Immunology Allergy. Basel, Karger.; vol. 89: 49-61
Levine, R.J.; Maynard, S.E.; Qian, C.; Lim, K.H.; England, L.J.; Yu, K.F.; Schisterman, E.F.; Thadhani, R.; Sachs, B.P.; Epstein, F.H.; Sibai, B.M.; Sukhatme, V.P.; Karumanchi, S.A., 2004. Circulatingangiogenic factors and the risk of preeclampsia. N. Engl. J. Med.,, 350(7), 672-683.
Levine R J, Lam C, Qian C, Yu K F, Maynard S E, Sachs B P, Sibai B M, Epstein F H, Romero Roberto, Thadhani Ravi, Karumanchi S A. 2006. Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia. The New England Journal of Medicine. ; 355: 992-1005
Lim Ji Hyae, Kim Shin Young, Park So Yeon, Yang Jae Hyug, Ki Moon Young, Ryu Hyun Mee. 2008. Effective Prediction of Preeclampsia by a Combined Ratio of Angiogenesis-Related Factors. Obstetric and Gynecology.; vol. 111: 1403-1409
Lindheimer M D, Taler S J, Cunningham F G. 2010. Hypertension in Pregnancy. Journal of The American Society of Hypertension. ; 4(2): 68-78
Liu Linda Y, Yang T, Ji, J, Wen Q, Morgan A A, Jin B, Chen G, Lyell D J, Stevenson D K, Ling Xuefeng B, Butte A J. 2013. Integrting Multiple ‘Omic’ Analyses Identifies Serological Protein Biomarkers for Preeclampsia. BMC Medicine.; 11 (236): 1-12
Matsubara keiichi, Matsubara Yuko, Ito M. 2009. The Utility of Vascular Dysfunction Studies in The Prediction and Prevention of Preeclampsia: a Historical Review. Vascular Disease Prevention.; 6: 163-169
Maynard S E, Min J Y, Merchan J, Lim Kee Hak, Li Jianyi, Mondal S, Libermann T A, Morgan J P, Sellke F W, Stillman I E, Epstein F H, Sukhatme V P, and Karumanchi S A. 2003. Excess Placental Soluble fms-Like Tyrosine Kinase 1 (sFlt-1) may Contribute to Endothelial Dysfunction, Hypertension and Proteinuria in Preeclampsia. J. Clin. Invest.; 111: 649-658
Maynard S E, Venkatesha S, Thadhani R, and Karumanchi S A. 2005. Soluble Fms-Like Tyrosine Kinase 1 and Endothelial Dysfunction in the Pathogenesis of Preeclampsia. Pediatric Research.; Vol. 57: 1-7
Mcelrath t F, Lim K H, Pare E, Edwards J R, Pucci D, Troisi R, Parry S. 2012.
Longitudinal Evaluation of Predictive Value for Preeclampsia of Circulating Angiogenic Factors Through Pregnancy. Am j Obstet Gynecol.; 207: 1-7
Mihalceanu Elena, Crauciuc Eduard, Toma Ovidiu, Ungureanu Eugen, Crauciuc Dragos, Onofriescu Mircea. 2013. Angiogenic Protein Ratio sFlt-1 / PlGF The Predictive Value for Preeclampsia. Analele Ştiinţifice ale Universităţii „Alexandru Ioan Cuza”, Secţiunea Genetică şi Biologie Moleculară, TOM XIV,
Mikat B, Gellhaus A, Wagner N, Birdir C, Kimmig R, and Koninger A. 2012.
Review Article Early Detection of Maternal Risk for Preeclampsia.
ISRN Obstetrics and Gynecology. ; 1-7
Moghadam A D, Khosravi A, Sayehmiri K. 2012. Predictive Factors for Preeclampsia in Pregnant Women: an Unvariate and Multivariate Logistic Regression Analysis. ACTABP.; Vol 59, No. 4: 673-677
Moore Simas, T.A.; Crawford, S.L.; Solitro, M.J.; Frost, S.C.;Meyer, B.A.; Maynard, S.E. 2007. Angiogenic factors for the predictionof preeclampsia in high-risk women. Am. J. Obstet. Gynecol.,197(3), 244.el-8.
Murphy S R, Lamarca B B D, Parrish M, Cockrell K, Granger J P. 2012. Control of Sluble Fms Like Tyrosine -1 (sFlt-1) Production Response to Placental Ischemia / Hypoxia: Role of Tumor Necrosis Factor –α. American Journal Physiol Regul Integr Comp Physiol.; 304: R130-R135
Myatt L, Clifton R G, Roberts J M, Spong C Y, Hauth J C, Varner M W, Thorp j M, Mercer B M, Peaceman a M, Ramin S M, Carpenter M W, Iams J D, Sciscione A, Harper M, Tolosa J E, Saade G, Sorokin Y, Anderson D G. 2012. First Trimester Prediction of Preeclampsia in Low Risk Nulliparous Women. Journal of Obstet and Gynecology.; 119: 1234-1242
Myers J E, Kenny L C, McCowan L M E, Chan E H Y, Dekker G A, Poston , Simpson n A B, North R . 2013. Angiogenic Factors Combined with Clinical Risk Factors to Predict Preterm Pre-Eclampsia in Nulliparous Women : a Predictive Test Accuracy Study.International Journal of Obstetric and Gynecology. ; 1-9
Nelson S M and Greer I A. 2006. Hypertensive Disorders of Pregnancy: Preventative, Immediate and Long Term Management. Expert Rev. Pharmacoeconomics Outcomes Res. ; 6: 541-554
Neufeld G, Cohen T, Gengrinovitch Stela, and Poltorak Z. 1999. Vascular Endothelial Growth Factor and Its Receptors. The FASEB Journal.; Vol. 13: 1-14
Noori Muna, Donald Ann E, Angelakopoulou Aspasia, Hingorani Aroon D, Williams David J. 2010. Prospective Study of Placental Angiogenic Factors and Maternal Vascular Function Before and After Preeclampsia and Gestationl Hypertension. Circulation Research. Journal of The American Heart Association. ; 122: 478-487
Noris M, Perico N, and Giuseppe R. 2005. Review:Mechanisms of Disease: Pre-Eclampsia.Nature Clinical Practice Nephrology.; Vol 1(2): 98-114
Odegård RA, Vatten LJ, Nilsen ST, Salvesen KA, 2000. Austgulen R.Risk factors and clinical manifestations of pre-eclampsia. BJOG; 107: 1410-6
Ohkuchi A, Hirashima C, Matsubara S, Takahashi K, Matsuda Y and Suzuki M. 2011. Threshold of Sluble Fms-Like Tyrosine Kinase 1/ Placental Growth Factor Ratio for The Imminent Onset of Preeclampsia. Hypertension Journal of The American Heart Association. ; 58: 859-866
Pennington kathleen A, Schlitt jessica M, Jackson Daniel L, Schulz Laura C, Schust Danny J. 2012. Preeclampsia : Multiple Approaches for a Multifactorial Disease. Disease Models and Mechanisms. ; 5: 9-18
Powe Camille E, Levine Richard J, Karumanchi S Ananth. 2011. Preeclampsia, a Disease of the Maternal Endothelium: The Role of Antiangiogenic Factors and Implications for Later Cardiovascular Disease. Circulation Research. Journal of The American Heart Association.; 123: 2856-2869
Powers Rober W, Jeyabalan Arun, Clifton Rebecca G, Dorsten PV, Hauth J C, Klebanoff MA, Lindheimer M D, Sibai Baha, Landon Mark, Miodovnik Menachem. 2010. Soluble fms-Like Tyrosine Kinase 1 (sFlt1), Endoglin and Placental Growth Factor (PlGF) in Preeclampsia among High Risk Pregnancies. PLoS ONE.; 5:1-12
Redman C W and Sargent I L. 2009. Placental Stress and Preeclampsia: a Revised View. Placenta.; 30: 38-42
Ringkasan Kajian Kesehatan Ibu dan Anak. Unicef Indonesia. Oktober 2012
Roberts J M and Escudero C. 2012. The Placenta in Preeclampsia. Pregnancy Hypertens. ; 2: 72-83
Roberts J M and Hubel. 2008. The Two Stage Model of Preeclampsia: Variations on The Theme. Placenta. : 1-6
Robert J M and Rajakumar A. 2009. Preeclampsia and Soluble Fms Like Tyrosine Kinase 1. J Clin Endocrinol Metab. ; 94: 2252-2254
Rogers M S, 2007. Prediction of Preeclampsia in Early Pregnancy.. Women’s Health.; 3: 571-583
Rolfo A, Giuffrida D, Nuzzo A M, Pierobon D, Cardaropoli S, Piccoli E, Giovarelli M, Todros T. 2013. Pro Inflammatory Profile of Preeclamptic Placental Mesenchymal Stromal Cells: New Insights into The Etiopathogenesis of Preeclampsia. PLoS One.; Vol. 8: 1-13
Romero R, Nien JK, Espinoza J, Todem David, Fu Wenjiang, Chung Hwan, Kusanovic Juan Pedro, Gotsch Francesca, Erez Offer, Mazaki-tovi Shali, Gomez Ricardo, Edwin Sam, Chaiworapongsa T, Levine R J, Karumanchi A. 2008. A longitudinal study ofangiogenic (placental growth factor) and anti-angiogenic (solubleendoglin and soluble vascular endothelial growth factor receptor-1)factors in normal pregnancy and patients destined to developpreeclampsia and deliver a small for gestational age neonate. JMatern Fetal Neonatal Med. 21: 9–23
Rozhikan. 2007. Faktor-Faktor Risiko Terjadinya Preeklampsia Berat Di Rumah Sakit dr. H. Soewondo Kendal. Tesis. Universitas Diponegoro. Semarang;
Sado T, Naruse K, Noguchi T, Haruta S, Yoshida S, Tanase Y, Kitanaka T, Oi H, Kobayashi H. 2011. Inflammatory Pattern Recognition Receptors and Their Ligands: Factors Contributing to Th Pathogenesis of Preeclampsia. ; 1-13
Savaj Shokoufeh and Vaziri N D. 2012. An Overview of Recent Advances in Pathogenesis and Diagnosis of Preeclampsia. IJKD.: 334-8
Savvidou MD, Akolekar R, Zaragoza E, Poon L C, Nicolaides K H. 2009. First Trimester Urinary Placental Growth factor and Development of Preeclampsia. BJOG.; 116: 643-647
Schmidt Markus, Dogan Canan, Birdir Canan, Kuhn Ulrich, Gllhaus Alexandra, Kimmig Rainer, Bauer Sabine Kasimir. 2009. Placental Growth Factor: A Predictive Marker for Preeclampsia? . Gynakol Geburtshilfliche Rundsch.; 49: 94-99
Selim M E, Elshmry N G, and Rashed E H. 2013. The Role of Novel Biomarker in Early Predicton of Preeclampsia in Pregnant Rats. J. Blood Disorders and Transfusion.; 4: 1-5
Shibuya M. 2006. Differential Roles of Vascular Endothelial Growth Factor Receptor-1 and Receptor-2 in Angiogenesis. Journal of Biochemistry and Molecular Biology. ; Vol 39 (5): 469-478.
Shibuya M. 2011. Review Involvement of Flt-1 (VEGF receptor-1) in Cancer and Preeclampsia. Proceedings of The Japan Academy, Series B Physical and Biological Scieces.; 87 (4): P. 167-179
Shibuya M. 2013. Vascular Endothelial Growth Factor and Its Receptor System: Physiological Functions in Angiogenesis and Pathological Roles in Various Diseases. Journal of Biochemistry.; 153: 13-19
Sibai B, Dekker G, Kupferminc M. 2005. Preeclampsia. The Lancet.. Vol. 365, Issue 9461: 785-799
Soto E, Romero R, Kusanovic J P, Ogge G, Hussein Y, Yeo L, Hassan S S, Kim C J, Chaiworapongsa T. 2012. Late Onset Preeclampsia is Associated with an Imbalance of Angiogenic and Anti Angiogenic Factors in Patients With and Without Placental Lesions Consistent With Maternal Underperfusion. J Matern Fetal Neonatal Med.; 25: 498-507
Tjoa ML, van Vugt JM, Mulders MA,Schutgens RB, Oudeians CB, Van Wijk IJ. 2001. Plasma placentagrowth factor levels in midtrimester pregnancies. Obstet Gynecol; 98: 600-7.
Torry, D.S.; Mukherjea, D.; Arroyo, J.; Torry, R.J. Expression andfunction of placenta growth factor: implications for abnormal placentation. 2003. J. Soc. Gynecol. Investig.; 10(4), 178-188.
Unicef, 2012. Ringkasan Kajian Kesehatan Ibu dan Anak. Jakarta: 1-6
Uzan J, Carbonnel M, Piconne O, Asmar R, Ayoubi J M. 2011. Preeclampsia: Pathophysiology, Diagnosis and Management. Vascular Health and Risk Management;: 467-474
Verdonk Koen, Visser Willy, Russcher Henk, Danser A H Jan, Steegers Eric A P and Meiracker Anton H van den. 2012. Differential Diagnosis of Preeclampsia: Remember the Soluble FMs-Like Tyrosine Kinase 1/Placental Growth Factor Ratio. Hypertension. American Heart Association Journals.; 60: 884-890
Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler Harald, Calda P, Holzgreve W, Galindo A, Engels T, Denk B, Stepan H. 2011.
The sFlt-1/PlGF Ratio in Different Types of Hypertensive Pregnancy Disorders and Its Prognostic Potential in Preeclamptic Patients. American Journal of Obstetric and Gynecology. ; 206: 1-8
Wagner L K. 2004. Diagnosis and Management of Preeclampsia. American Family Physician. ; Vol 70, Number 12: 2317-2324
Wang Alice, Rana Sarosh, Karumanchi S Ananth. 2009. Preeclampsia: The Role of Angiogenic Factors in Its Pathogenesis. Physiology. : 24: 147-158
Yamamoto Tatsuo, Chishima Fumihisa, Matsuura Masahiko. 2013. Prediction of Preeclampsia Using Angiogenic and Antiangiogenic Factors.Hypertension Research in Pregnancy. ; 1: 66-70
Zhong Yan. Tuuli M, and Odibo A O. 2010. First Trimester Assessment of Placenta Function and The Prediction of Preeclampsia and Intrauterine Growth Restriction. Prenatal Diagnosis.; 30: 293-308
Zhou Qiong, Qiao Fu-Yuan, Zhao Chang, Liu Hai-Yi. 2011. Hypoxic Trophoblast-derived sFlt-1 May Contribute to Endothelial Dysfunction: Implication for the Mechanism of Trophoblast-Endothelial Dysfunction in Preeclampsia. Cell Biology International.; 35: 61-66
